Plicit Capital Corp. Files Filing Statement and Receives TSXV Conditional Approval Regarding Qualifying Transaction With 3D Signatures Inc.

CALGARY, AB--(Marketwired - August 24, 2016) - Plicit Capital Corp. (TSX VENTURE: PLP.H) ("Plicit" and/or the "Company"), a capital pool company, is pleased to announce that it has filed a filing statement (the "Filing Statement") regarding its proposed qualifying transaction (the "Qualifying Transaction") with 3D Signatures Inc. ("3D") and received conditional approval from the TSX Venture Exchange ("TSXV") for the Qualifying Transaction.

In connection with the Qualifying Transaction, the Company will acquire all of the issued and outstanding securities of 3D by way of a three-cornered amalgamation whereby 3D will amalgamate with a wholly-owned subsidiary of the Company. Closing of the Qualifying Transaction is expected to occur on or about August 31, 2016, or such other date as Plicit and 3D may determine.

The completion of the Qualifying Transaction is subject to a number of conditions, including but not limited to receipt of all required regulatory consents, including final TSXV acceptance, and satisfaction of other customary closing conditions, including the closing of a concurrent brokered private placement of common shares at a price of $0.35 per share for gross proceeds of not less than $5,000,000 CAD (the "Financing"). The Financing will be sold through Haywood Securities Inc. as the lead selling agent and sponsor of the Qualifying Transaction in accordance with the rules and policies of the TSXV. There can be no assurance that the Qualifying Transaction will be completed as proposed or at all.

Trading in the common shares of Plicit is currently halted and will resume under the symbol "DXD" following publication of the Final Exchange Bulletin by the TSXV in respect of the closing of the Qualifying Transaction.

Investors are cautioned that, except as disclosed in the Filing Statement, any information released or received with respect to the Qualifying Transaction may not be accurate or complete and should not be relied upon. Trading in the securities of a capital pool company should be considered highly speculative.

Please see the Filing Statement, which is available on SEDAR at www.sedar.com., for more information regarding the Qualifying Transaction, 3D and its business. The Company will issue additional news releases related to the Qualifying Transaction and other material information as it becomes available.

About 3D Signatures Inc.

3D Signatures Inc. is a personalized medicine company with a proprietary software platform based on the three dimensional analysis of telomere organization. The technology is well developed and supported by 16 clinical studies on over 1500 patients on 13 different cancers and Alzheimer's disease. Depending on the application, the technology can measure the stage of disease, rate of progression of disease, drug efficacy, and drug toxicity. The technology is designed to predict the course of disease and to personalize treatment for the individual patient. For more information, visit: www.3dsignatures.com.